The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Non-Malignant Channel is supported with funding from Agios (Gold).
The Thalassemia Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
General Updates | Preventing and managing bone disease in patients with thalassemia
Julian Waung, BM, PhD, Whittington Hospital, London, UK, briefly comments on how to prevent bone disease in patients with thalassemia, emphasizing the importance of maximizing peak bone mass in early life and maintaining it as patients age. If bone disease does develop, Dr Waung highlights the importance of using anabolic treatment early on, if the patient is eligible for this. This interview took place virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
So I think the first plank is to try to build up as much bone as possible during the growth phase. So peak bone mass is reached in the late 20s and early 30s. So it’s about having adequate calcium intake, optimal hormone status, and exercise during youth so that the bones are as big as they can be, and then preserving that bone as much as possible again, with consideration of lifestyle factors and optimizing hormone status, and ensuring the patient is well chelated...
So I think the first plank is to try to build up as much bone as possible during the growth phase. So peak bone mass is reached in the late 20s and early 30s. So it’s about having adequate calcium intake, optimal hormone status, and exercise during youth so that the bones are as big as they can be, and then preserving that bone as much as possible again, with consideration of lifestyle factors and optimizing hormone status, and ensuring the patient is well chelated. So those would be the factors to prevent bone disease.
And then if intervention with medication is required, being confident to use pharmacological treatment, and there’s now a shift towards using anabolic treatment earlier if the patient qualifies for it, and it’s possible because we know that bone is built up more if they’ve not had lots of anti-resorptive, which is more conventional, treatment first.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
